25I-NBOH
25I-NBOH[edit | edit source]
25I-NBOH, also known as 2C-I-NBOH, is a potent psychedelic compound that belongs to the N-benzylphenethylamine class. It is a derivative of the phenethylamine 2C-I and is closely related to the NBOMe series of compounds. 25I-NBOH is known for its strong binding affinity to the 5-HT2A receptor, which is believed to be responsible for its psychedelic effects.
Chemical Structure[edit | edit source]
25I-NBOH is chemically similar to 2C-I, with the addition of a 2-hydroxybenzyl group attached to the nitrogen atom of the phenethylamine backbone. This modification increases its potency and alters its pharmacological profile compared to its parent compound, 2C-I.
Pharmacology[edit | edit source]
The primary mechanism of action for 25I-NBOH is its agonistic activity at the 5-HT2A receptor, a subtype of the serotonin receptor that is implicated in the modulation of mood, perception, and cognition. The compound's high affinity for this receptor is thought to underlie its psychedelic effects, which can include altered visual and auditory perceptions, changes in thought patterns, and emotional experiences.
Effects[edit | edit source]
The effects of 25I-NBOH are similar to those of other psychedelics, such as LSD and psilocybin. Users may experience visual hallucinations, synesthesia, and a distorted sense of time. The intensity and duration of these effects can vary depending on the dose and individual sensitivity.
Safety and Toxicity[edit | edit source]
As with many research chemicals, the safety profile of 25I-NBOH is not well-established. There have been reports of adverse effects, including vasoconstriction, tachycardia, and hypertension, particularly at higher doses. Due to its potency and the potential for overdose, caution is advised when handling this compound.
Legal Status[edit | edit source]
The legal status of 25I-NBOH varies by country. In some jurisdictions, it is classified as a controlled substance, while in others, it may be legal or unregulated. It is important to be aware of the local laws regarding the possession and use of this compound.
Related Compounds[edit | edit source]
See Also[edit | edit source]
Related Pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
